Launching a clinical trial for a drug intended to treat severe asthma during a respiratory pandemic — particularly one that seems to hit people with some types of asthma particularly hard — could be a risky move.
November 30, 2020 | In the News
Startup Spotlight: Bullish on its asthma treatment, Kinaset forges ahead in unusual times
November 20, 2020 | LifeSciVC
Biotech: The Featherweight Champion Of The Markets
Biotech punches way above its weight-class, and that’s never been more apparent than in this pandemic and the race for a COVID vaccine.
November 16, 2020 | Press Release
Atlas Venture Welcomes Rajesh Devraj, PhD, as Venture Partner
Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced today that Rajesh (Raj) Devraj, PhD, is joining the firm as a venture partner. Devraj will be working with the Atlas team to identify and execute upon compelling opportunities for new biotechnology company creation.
October 29, 2020 | In the News
Novartis buys a new gene therapy for vision loss, and this is one preclinical venture that didn’t come cheap
Cyrus Mozayeni got excited when he began to explore the academic work of Ehud Isacoff and John G. Flannery at UC Berkeley.
October 27, 2020 |
Negotiating 101: Advice From The Trenches
In a recent blog post, I walked through my tips for reading your adversaries’ body language while maintaining your own poker face throughout negotiations.
In this second post, I’ll share practical tactics for gaining leverage and using it wisely. Women of biotech, there’s also a special section for you – so read on!
By Deanna Petersen, Chief Business Officer of AVROBIO, as part of the From The Trenches feature of LifeSciVC.